San\u0101ksmes laik\u0101 partneri prezent\u0113s jaun\u0101kos rezult\u0101tus projekt\u0101, k\u0101 ar\u012b p\u0101rrun\u0101s da\u017e\u0101dus administrat\u012bvos jaut\u0101jumus. <\/p>\n
L\u012bdztekus projekta aktualit\u0101\u0161u apsprie\u0161anai 28. j\u016bnij\u0101 plkst. 10.00 notiks ar\u012b Baltijas valst\u012bm noz\u012bm\u012bgs pas\u0101kums \u2013 izgl\u012btojo\u0161s semin\u0101rs par da\u013ci\u0146u terapiju. \u0160aj\u0101 semin\u0101r\u0101 ir aicin\u0101ti piedal\u012bties onkologi, radiologi, medic\u012bnas fizi\u0137i, citi speci\u0101listi un studenti no Latvijas, Lietuvas un Igaunijas. Semin\u0101rs ir cie\u0161i saist\u012bts ar Eiropas Kodolp\u0113tniec\u012bbas centra (CERN) Baltijas grupas iniciat\u012bvu, kas paredz inovat\u012bva da\u013ci\u0146u terapijas centra izveidi Baltijas valst\u012bs. Semin\u0101r\u0101 starptautiskie eksperti dal\u012bsies zin\u0101\u0161an\u0101s un pieredz\u0113 par da\u017e\u0101diem da\u013ci\u0146u terapijas aspektiem un to, kas b\u016btu j\u0101\u0146em v\u0113r\u0101, projekt\u0113jot da\u013ci\u0146u terapijas centru. Lai piedal\u012btos pas\u0101kum\u0101, l\u016bgums re\u0123istr\u0113ties, aizpildot anketu.<\/p>\n
\u0160\u012b ir noz\u012bm\u012bga projekta iniciat\u012bva, jo Baltijas valstis ir viens no Eiropas re\u0123ioniem, kur nav pieejama da\u013ci\u0146u terapija. Da\u013ci\u0146u terapija pav\u0113rtu inovat\u012bvas \u0101rstniec\u012bbas iesp\u0113jas da\u017e\u0101diem v\u0113\u017ea veidiem Baltijas re\u0123ion\u0101, k\u0101 ar\u012b \u0161\u0101ds centrs \u013cautu nodarboties ar zin\u0101tnisko p\u0113tniec\u012bbu, lai att\u012bst\u012btu arvien jaunas metodes, k\u0101 c\u012bn\u012bties ar onkolo\u0123iskaj\u0101m slim\u012bb\u0101m. <\/p>\n
V\u0113zis ir noz\u012bm\u012bga sabiedr\u012bbas vesel\u012bbas probl\u0113ma, t\u0101p\u0113c ar\u012b HITRIplus projekt\u0101 notiek p\u0113t\u012bjumi par slim\u012bbas \u0101rst\u0113\u0161anu ar smago jonu terapiju, vienlaikus att\u012bstot ar\u012b tai nepiecie\u0161amos instrumentus. Paredz\u0113ts, ka, \u012bstenojot projektu, tiks pilnveidota pa\u0161reiz\u0113j\u0101 da\u013ci\u0146u terapija un onkologiem tiks pied\u0101v\u0101tas jaunas \u0101rstniec\u012bbas metodes gad\u012bjumos, kad pa\u0161reiz\u0113j\u0101s metodes nav pietiekami iedarb\u012bgas, t\u0101 n\u0101kotn\u0113 nodro\u0161inot pacientu augst\u0101ku izdz\u012bvo\u0161anas varb\u016bt\u012bbu un maz\u0101ku audz\u0113ju atk\u0101rto\u0161anas iesp\u0113ju. <\/p>\n
HITRIplus projekt\u0101 ir apvienoju\u0161ies 18 partneri no Eiropas \u2013 da\u013ci\u0146u un pa\u0101trin\u0101t\u0101ju p\u0113tniec\u012bbas centri, zin\u0101tniskie instit\u016bti, universit\u0101tes un industrijas p\u0101rst\u0101vji, ar\u012b RTU. Viens no partneriem ir CERN, kuram ir kompetence pa\u0101trin\u0101t\u0101ju projekt\u0113\u0161an\u0101 un ekspluat\u0101cij\u0101, k\u0101 ar\u012b zin\u0101\u0161anas par sinhrotroniem un jonu avotiem, staru k\u016b\u013ca dinamiku, kontroles sist\u0113m\u0101m un diagnostikas instrumentiem. Savuk\u0101rt RTU iesaist\u012bjusies, sniedzot savu kompetenci ma\u0161\u012bnb\u016bv\u0113 un in\u017eenierzin\u0101tn\u0113s, darbu veicot cie\u0161\u0101 sadarb\u012bb\u0101 ar CERN kol\u0113\u0123iem. <\/p>\n","protected":false},"excerpt":{"rendered":"
San\u0101ksmes laik\u0101 partneri prezent\u0113s jaun\u0101kos rezult\u0101tus projekt\u0101, k\u0101 ar\u012b p\u0101rrun\u0101s da\u017e\u0101dus administrat\u012bvos jaut\u0101jumus. L\u012bdztekus projekta aktualit\u0101\u0161u apsprie\u0161anai 28. j\u016bnij\u0101 plkst. 10.00 notiks ar\u012b Baltijas valst\u012bm noz\u012bm\u012bgs pas\u0101kums \u2013 izgl\u012btojo\u0161s semin\u0101rs par da\u013ci\u0146u terapiju. \u0160aj\u0101 semin\u0101r\u0101 ir aicin\u0101ti piedal\u012bties onkologi, radiologi, medic\u012bnas fizi\u0137i, citi speci\u0101listi un studenti no Latvijas, Lietuvas un Igaunijas. Semin\u0101rs ir cie\u0161i saist\u012bts […]<\/p>\n","protected":false},"author":6,"featured_media":475,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[38],"tags":[],"class_list":["post-546","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"meta_box":[],"_links":{"self":[{"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/posts\/546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/comments?post=546"}],"version-history":[{"count":1,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/posts\/546\/revisions"}],"predecessor-version":[{"id":547,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/posts\/546\/revisions\/547"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/media\/475"}],"wp:attachment":[{"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/media?parent=546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/categories?post=546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ippat.rtu.lv\/en\/wp-json\/wp\/v2\/tags?post=546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}